|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 16 of 22 found articles
| Title: |
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial |
| Author: |
Döhner, Hartmut Weber, Daniela Krzykalla, Julia Fiedler, Walter Kühn, Michael W M Schroeder, Thomas Mayer, Karin Lübbert, Michael Wattad, Mohammed Götze, Katharina Fransecky, Lars Koller, Elisabeth Wulf, Gerald Schleicher, Jan Ringhoffer, Mark Greil, Richard Hertenstein, Bernd Krauter, Jürgen Martens, Uwe M Nachbaur, David Samra, Maisun Abu Machherndl-Spandl, Sigrid Basara, Nadezda Leis, Claudia Schrade, Anika Kapp-Schwoerer, Silke Cocciardi, Sibylle Bullinger, Lars Thol, Felicitas Heuser, Michael Paschka, Peter Gaidzik, Verena I Saadati, Maral Benner, Axel Schlenk, Richard F Döhner, Konstanze Ganser, Arnold |
| Appeared in: |
The Lancet. Haematology |
| Paging: | Volume 10 () nr. 7 pages e495-e509 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 16 of 22 found articles
| << previous | next >> |